Avanos Medical, Inc.
AVNS
$12.71
-$0.39-2.98%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.84% | 3.64% | -0.53% | 1.36% | 4.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.84% | 3.64% | -0.53% | 1.36% | 4.27% |
| Cost of Revenue | 8.98% | 4.21% | 2.24% | 6.28% | 5.01% |
| Gross Profit | -5.27% | 3.16% | -2.72% | -2.25% | 3.72% |
| SG&A Expenses | -8.35% | 13.21% | -5.42% | -18.82% | -6.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -900.00% | 30.00% | -160.00% | 2,000.00% | -83.33% |
| Total Operating Expenses | -2.42% | 9.28% | -1.79% | -6.71% | -2.60% |
| Operating Income | 106.00% | -48.24% | 13.01% | 657.14% | 181.97% |
| Income Before Tax | 546.67% | -4,824.72% | 465.38% | 221.57% | 116.48% |
| Income Tax Expenses | 210.00% | -1,019.05% | -41.94% | 337.50% | 176.92% |
| Earnings from Continuing Operations | 1,220.00% | -3,709.09% | 167.05% | 200.00% | 106.41% |
| Earnings from Discontinued Operations | -- | 40.00% | -131.37% | 96.08% | -119.18% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 833.33% | -3,883.81% | 216.22% | 102.64% | -80.00% |
| EBIT | 106.00% | -48.24% | 13.01% | 657.14% | 181.97% |
| EBITDA | 21.34% | -30.18% | 22.61% | 144.68% | 173.33% |
| EPS Basic | 834.36% | -3,899.82% | 218.20% | 102.69% | -82.24% |
| Normalized Basic EPS | 289.05% | -53.54% | 31.90% | 332.01% | 127.70% |
| EPS Diluted | 800.00% | -3,900.70% | 205.80% | 102.47% | -50.38% |
| Normalized Diluted EPS | 286.57% | -53.14% | 30.24% | 329.96% | 127.46% |
| Average Basic Shares Outstanding | -0.22% | -0.43% | -1.71% | -1.92% | -0.86% |
| Average Diluted Shares Outstanding | 0.21% | -1.29% | -0.43% | -1.07% | 0.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |